3 Great Reasons to Buy Gilead Sciences Stock
Like many people, I'm rooting for Gilead Sciences' (NASDAQ: GILD) experimental drug remdesivir to be successful in clinical studies targeting COVID-19. There have been some early hints at positive results, but it's too soon to know for sure how safe and effective remdesivir will actually be in treating the novel coronavirus disease.
In the meantime, I think that Gilead Sciences is a great stock to buy regardless of what happens with its coronavirus program. Here are three reasons why.
Source Fool.com